Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: sense who wrote (174510)	7/9/2021 6:07:52 PM
From: TobagoJack	Respond to of 217709

Re <<of those that I'm not going to take ?>> I was asked the question about vaccination by others here in HK, and my standard answer is the same to all, that "I am going to delay vaccination as long as possible. Let's see what if any vaccination is required by the schools for the kids. Should I be required to take a vaccine right now, I would take the Sinovac, because at best it works to keep me out of the hospital and away from death, and at worst it precludes me from getting micro-blood-clot damaged by new fangled vaccines" I 'wait for it' and remain agnostic. But yes, am anticipating unknowns to become not-unknowns, and should the numbers tell unexpected on any of the vaccines, except the traditional vaccines, can only be bad to very bad news. There, at this juncture, is no upside to the new fangled vaccines, seems to me, for it isn't working, never mind the %s, and is complicated, with unknown LT effects and unknowable cumulative effects. China Fosun does have the license to produce the BioNTech vaccine, but ... am wondering what if anything China regulatory knows and is in effect warning the world through actions scmp.com Will slow approval of BioNTech and other foreign vaccines block China from reopening its borders? 200,000 of 845,000 foreigners living in the mainland have had the jab but many may be holding out for a foreign shot Little data on Sinopharm, Sinovac efficacy in high-incidence areas as they were introduced when infectious rates ‘near zero’, expert says